Stock listing
Kymera Therapeutics, Inc.
Selected listing: KYMR · NASDAQ · USD · US
Kymera Therapeutics, Inc. (NASDAQ:KYMR), Health Technology. Latest release Sep 1, 2026: Kymera Therapeutics Announces Presentations on KT-621…
- Ticker
- NASDAQ:KYMR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. (Ticker: KYMR) is a public company based in the United States, focused on developing innovative therapies through its proprietary technology. The company's advancements in drug development highlight its commitment to improving patient outcomes.
Latest news from Kymera Therapeutics, Inc.
Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses
September 1, 2026
Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
August 5, 2026
Kymera International Appoints Willson Ropp as Chief Executive Officer
July 29, 2026
Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026
July 28, 2026
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
July 27, 2026
Events
Research Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. company profile
View the public company page for Kymera Therapeutics, Inc. on 6ix.
Kymera Therapeutics, Inc. news
Read company news and market updates connected to Kymera Therapeutics, Inc..
Kymera Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Kymera Therapeutics, Inc..